Our Pipeline

MENOPAUSAL HOT FLASHES – With concerns about risks associated with hormone replacement therapy, a new treatment option is needed for women experiencing menopausal hot flashes. Our extended release tablets are designed to provide women with prolonged relief with potential for reduced side effects.

POSTHERPETIC NEURALGIA – Nerve damage caused by shingles frequently results in severe and persistent pain. Our extended release tablets are designed to provide patients with pain relief throughout the day, with potential for reduced side effects commonly associated with pain medications.

GASTROESOPHAGEAL REFLUX DISEASE (GERD) – Nocturnal acid breakthrough continues to affect approximately half of the patients already receiving treatment for GERD. Our formulation is designed to provide these patients with relief that gets them through the night.

PARKINSON’S DISEASE – Levodopa/Carbidopa has significant limitations with inconsistent efficacy and inconvenient dosing. Our formulation could optimize Levodopa/Carbidopa’s window of absorption and thus could smooth out blood level fluctuations.